{"id":837,"date":"2024-11-13T21:57:02","date_gmt":"2024-11-13T12:57:02","guid":{"rendered":"https:\/\/www.sonire-therapeutics.com\/?p=837"},"modified":"2025-11-25T19:32:27","modified_gmt":"2025-11-25T10:32:27","slug":"medica2024_presentation","status":"publish","type":"post","link":"https:\/\/www.sonire-therapeutics.com\/en\/medica2024_presentation\/","title":{"rendered":"SONIRE Therapeutics CEO Tohru Satoh to speak at MEDICA 2024"},"content":{"rendered":"\n

SONIRE Therapeutics Inc. (Headquarters: Tokyo, Japan; President and CEO, Founder: Tohru Satoh; hereinafter referred to as “SONIRE”), announces that Mr. Tohru Satoh will be speaking at the Future of Therapy session of Pitch Event at MEDICA 2024, the world’s largest medical equipment trade fair, to be held in D\u00fcsseldorf, Germany from 11th to 14th November 2024. The title of the presentation will be \u201cCancer treatment using ultrasound technology\u201d.<\/p>\n\n\n\n

Date and time:
November 13th<\/sup> (Wed) 12:45 – 12:55 (CET) (20:45 – 20:55 (JST))
Place: MEDICA INNOVATION FORUM (MIF) Hall 13 Booth E63 <\/p>\n\n\n\n

For information on the presentations, please refer to the following website.
https:\/\/www.medica-tradefair.com\/en\/Program\/Programoverview?ems_event=mif-cancer-treatment-using-ultrasound-technology-432066<\/a><\/p>\n\n\n\n

SONIRE will continue to promote our business in order to realize the wish we put in our company name at the time of our foundation: ” Sonics brings new future full of hope to as many cancer patients and their families as possible.”.<\/p>\n\n\n\n

\n
Download PDF file<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SONIRE Therapeutics Inc. (Headquarters: Tokyo, Japan; President and CEO, Founder: Tohru Satoh; hereinafter referred to as “SONIRE”), announces that Mr. Tohru Satoh will be speaking at the Future of Therapy session of Pitch Event at MEDICA 2024, the world’s largest medical equipment trade fair, to be held in D\u00fcsseldorf, Germany from 11th to 14th November […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_locale":"en_US","_original_post":"https:\/\/www.sonire-therapeutics.com\/?p=831","footnotes":""},"categories":[16],"tags":[],"class_list":["post-837","post","type-post","status-publish","format-standard","hentry","category-event","en-US"],"_links":{"self":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/comments?post=837"}],"version-history":[{"count":5,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/837\/revisions"}],"predecessor-version":[{"id":842,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/837\/revisions\/842"}],"wp:attachment":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/media?parent=837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/categories?post=837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/tags?post=837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}